Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: A4IBU3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 77 | 79 | PF00675 | 0.442 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.512 |
CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.334 |
DOC_MAPK_gen_1 | 14 | 23 | PF00069 | 0.397 |
DOC_MAPK_MEF2A_6 | 16 | 25 | PF00069 | 0.379 |
DOC_PP4_FxxP_1 | 112 | 115 | PF00568 | 0.383 |
DOC_USP7_MATH_1 | 106 | 110 | PF00917 | 0.369 |
DOC_USP7_MATH_1 | 71 | 75 | PF00917 | 0.434 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.628 |
LIG_Actin_WH2_2 | 32 | 47 | PF00022 | 0.288 |
LIG_BRCT_BRCA1_1 | 108 | 112 | PF00533 | 0.569 |
LIG_BRCT_BRCA1_1 | 72 | 76 | PF00533 | 0.515 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.470 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.343 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.489 |
LIG_FHA_2 | 51 | 57 | PF00498 | 0.382 |
LIG_FHA_2 | 95 | 101 | PF00498 | 0.392 |
LIG_IRF3_LxIS_1 | 36 | 42 | PF10401 | 0.278 |
LIG_LIR_Apic_2 | 109 | 115 | PF02991 | 0.344 |
LIG_LIR_Gen_1 | 99 | 108 | PF02991 | 0.379 |
LIG_LIR_Nem_3 | 99 | 104 | PF02991 | 0.383 |
LIG_SH2_STAT3 | 87 | 90 | PF00017 | 0.303 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.454 |
LIG_SH2_STAT5 | 88 | 91 | PF00017 | 0.352 |
LIG_SH3_3 | 105 | 111 | PF00018 | 0.445 |
LIG_TYR_ITIM | 36 | 41 | PF00017 | 0.270 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.610 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.394 |
MOD_CK2_1 | 50 | 56 | PF00069 | 0.328 |
MOD_GlcNHglycan | 6 | 9 | PF01048 | 0.530 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.380 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.429 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.403 |
MOD_N-GLC_2 | 27 | 29 | PF02516 | 0.344 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.515 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.336 |
MOD_Plk_4 | 50 | 56 | PF00069 | 0.383 |
MOD_Plk_4 | 82 | 88 | PF00069 | 0.408 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.626 |
MOD_SUMO_rev_2 | 42 | 52 | PF00179 | 0.359 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.281 |
TRG_ER_diArg_1 | 76 | 78 | PF00400 | 0.453 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5B2 | Leptomonas seymouri | 70% | 100% |
A0A1X0P535 | Trypanosomatidae | 51% | 94% |
A0A3Q8IVH8 | Leishmania donovani | 99% | 100% |
A0A3R7MNW4 | Trypanosoma rangeli | 54% | 100% |
A4HN75 | Leishmania braziliensis | 83% | 100% |
C9ZYR9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9AFN0 | Leishmania major | 88% | 100% |
E9B6T3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |